Lipigon Pharmaceuticals AB Cash Flow Quality Index
Lipigon Pharmaceuticals AB cash flow quality index. Lipigon Pharmaceuticals AB (LPGO) has a Cash Flow Quality Index of -1.46x as of June 2023. Operating cash flow of Skr-10.38 Million is below net income of Skr7.13 Million, suggesting accrual-heavy earnings not yet converted to cash. See Lipigon Pharmaceuticals AB financial flexibility index to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Lipigon Pharmaceuticals AB Cash Flow Quality Index by Year (None–None)
Lipigon Pharmaceuticals AB cash flow quality index by year from None to None. Year-by-year earnings quality comparison for Lipigon Pharmaceuticals AB. For the full cash flow conversion analysis, see Lipigon Pharmaceuticals AB cash conversion from operations.
| Year | Quality Index | Operating CF (SEK) | Net Income | YoY Change |
|---|